The U.S. Food and Drug Administration (FDA) has reclassified a recent recall involving Dr Pepper Zero Sugar as a Class II alert, due to health concerns stemming from incorrect labeling. Over 19,000 cases are affected.

Originally announced on May 23, the recall involves 12-ounce cans packaged in 12- and 24-packs, produced at a Pepsi Beverages facility in Jacksonville, Florida.

These cans, bearing the product code XXXXRS05165 and a best-before date of February 16, 2026, were labeled as “zero sugar” but actually contained the full sugar content typical of regular Dr Pepper—about 39 grams per can. The products were shipped exclusively to retailers in Florida, Georgia, and South Carolina.

Customers who bought these cans are being encouraged to either return them to the store for a refund or dispose of them. The recall is limited to the Dr Pepper Zero Sugar product and does not affect any other Dr Pepper items.

A Class II recall, as defined by the FDA, indicates that the product may cause temporary or medically treatable health issues. Although the risk of serious harm is considered low, it is higher than in a Class III recall, which is reserved for products unlikely to pose health hazards.

The mislabeling could be particularly dangerous for individuals who must avoid sugar for medical reasons, such as people with diabetes. Ingesting unexpected amounts of sugar can lead to hyperglycemia—a condition where blood sugar levels become abnormally high. 

Symptoms can include blurred vision, fatigue, and excessive thirst. If left untreated, hyperglycemia may progress to a more serious condition called diabetic ketoacidosis, which can be life-threatening, according to the Cleveland Clinic.